Request for Covid-19 Impact Assessment of this Report
Geographically, the global Pharmaceutical Contract Manufacturing market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Pharmaceutical Contract Manufacturing market in North America.
Significant participants active in the global Pharmaceutical Contract Manufacturing market include: Famar S.A., Pfizer Centresource, Lonza, Recipharm AB, Patheon Inc., Aenova, Jubilant Life Sciences Ltd., Catalent Inc., Boehringer Ingelheim International GmbH., Baxter BioPharma Solutions...
Global Pharmaceutical Contract Manufacturing Market Segmentation:
Pharmaceutical Contract Manufacturing market, by Pharmaceutical Contract Manufacturing type:
API
FDF (Solid Dose, Liquid Dose, Injectable Dose)
…
Pharmaceutical Contract Manufacturing market, by Application:
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
Endocrinology
Others
…
Pharmaceutical Contract Manufacturing Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Pharmaceutical Contract Manufacturing by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Pharmaceutical Contract Manufacturing Market-Segmentation
4.1 By Type
4.1.1 API
4.1.2 FDF (Solid Dose, Liquid Dose, Injectable Dose)
4.2 By End-User/Application Industry
4.2.1 Oncology
4.2.2 Central nervous system
4.2.3 Cardiovascular disorder
4.2.4 Infectious diseases
4.2.5 Pulmonary disorders
4.2.6 Metabolic disorder
4.2.7 Gastrointestinal disorders
4.2.8 Musculoskeletal disorders
4.2.9 Genitourinary disorders
4.2.10 Endocrinology
4.2.11 Others
4.3 By Geography
4.3.1 North America Pharmaceutical Contract Manufacturing Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Pharmaceutical Contract Manufacturing Production from 2014-2020
4.3.1.2 North America Pharmaceutical Contract Manufacturing Consumption from 2014-2020
4.3.1.3 North America Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
4.3.1.4 North America Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe Pharmaceutical Contract Manufacturing Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Pharmaceutical Contract Manufacturing Production from 2014-2020
4.3.2.2 Europe Pharmaceutical Contract Manufacturing Consumption from 2014-2020
4.3.2.3 Europe Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
4.3.2.4 Europe Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Pharmaceutical Contract Manufacturing Production from 2014-2020
4.3.3.2 Asia-Pacific Pharmaceutical Contract Manufacturing Consumption from 2014-2020
4.3.3.3 Asia-Pacific Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America Pharmaceutical Contract Manufacturing Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Pharmaceutical Contract Manufacturing Production from 2014-2020
4.3.4.2 Latin America Pharmaceutical Contract Manufacturing Consumption from 2014-2020
4.3.4.3 Latin America Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
4.3.4.4 Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa Pharmaceutical Contract Manufacturing Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Pharmaceutical Contract Manufacturing Production from 2014-2020
4.3.5.2 Middle East & Africa Pharmaceutical Contract Manufacturing Consumption from 2014-2020
4.3.5.3 Middle East & Africa Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Famar S.A.
5.1.1 Famar S.A. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Famar S.A. Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Pfizer Centresource
5.2.1 Pfizer Centresource Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Pfizer Centresource Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Lonza
5.3.1 Lonza Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Lonza Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Recipharm AB
5.4.1 Recipharm AB Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Recipharm AB Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Patheon Inc.
5.5.1 Patheon Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Patheon Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Aenova
5.6.1 Aenova Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Aenova Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Jubilant Life Sciences Ltd.
5.7.1 Jubilant Life Sciences Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Jubilant Life Sciences Ltd. Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Catalent Inc.
5.8.1 Catalent Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Catalent Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Boehringer Ingelheim International GmbH.
5.9.1 Boehringer Ingelheim International GmbH. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Boehringer Ingelheim International GmbH. Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Baxter BioPharma Solutions
5.10.1 Baxter BioPharma Solutions Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Baxter BioPharma Solutions Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global Pharmaceutical Contract Manufacturing Market from 2021-2026
7.1 Future Forecast of Global Pharmaceutical Contract Manufacturing Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global Pharmaceutical Contract Manufacturing Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global Pharmaceutical Contract Manufacturing Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global Pharmaceutical Contract Manufacturing Market Value ($) and Growth Rate of Pharmaceutical Contract Manufacturing from 2014-2026
Global Pharmaceutical Contract Manufacturing Production and Growth Rate Segment by Product Types from 2014-2026F
Global Pharmaceutical Contract Manufacturing Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Pharmaceutical Contract Manufacturing Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Pharmaceutical Contract Manufacturing Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure API of Pharmaceutical Contract Manufacturing
Figure FDF (Solid Dose, Liquid Dose, Injectable Dose) of Pharmaceutical Contract Manufacturing
Table Global Pharmaceutical Contract Manufacturing Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Pharmaceutical Contract Manufacturing Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Oncology of Pharmaceutical Contract Manufacturing
Figure Central nervous system of Pharmaceutical Contract Manufacturing
Figure Cardiovascular disorder of Pharmaceutical Contract Manufacturing
Figure Infectious diseases of Pharmaceutical Contract Manufacturing
Figure Pulmonary disorders of Pharmaceutical Contract Manufacturing
Figure Metabolic disorder of Pharmaceutical Contract Manufacturing
Figure Gastrointestinal disorders of Pharmaceutical Contract Manufacturing
Figure Musculoskeletal disorders of Pharmaceutical Contract Manufacturing
Figure Genitourinary disorders of Pharmaceutical Contract Manufacturing
Figure Endocrinology of Pharmaceutical Contract Manufacturing
Figure Others of Pharmaceutical Contract Manufacturing
Table Global Pharmaceutical Contract Manufacturing Production Value ($) by Regions
Table Global Pharmaceutical Contract Manufacturing Production Value Share by Regions
Table Global Pharmaceutical Contract Manufacturing Production by Regions
Table Global Pharmaceutical Contract Manufacturing Production Share by Regions
Table Global Pharmaceutical Contract Manufacturing Consumption by Regions
Table Global Pharmaceutical Contract Manufacturing Consumption Share by Regions
Figure North America Pharmaceutical Contract Manufacturing Production and Growth Rate from 2014-2020
Figure North America Pharmaceutical Contract Manufacturing Consumption and Growth Rate from 2014-2020
Table North America Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
Table North America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
Table North America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
Table North America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
Figure Europe Pharmaceutical Contract Manufacturing Production and Growth Rate from 2014-2020
Figure Europe Pharmaceutical Contract Manufacturing Consumption and Growth Rate from 2014-2020
Table Europe Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
Table Europe Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
Table Europe Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
Table Europe Pharmaceutical Contract Manufacturing Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific Pharmaceutical Contract Manufacturing Production and Growth Rate from 2014-2020
Figure Asia-Pacific Pharmaceutical Contract Manufacturing Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
Table Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
Figure Latin America Pharmaceutical Contract Manufacturing Production and Growth Rate from 2014-2020
Figure Latin America Pharmaceutical Contract Manufacturing Consumption and Growth Rate from 2014-2020
Table Latin America Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
Table Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa Pharmaceutical Contract Manufacturing Production and Growth Rate from 2014-2020
Figure Middle East & Africa Pharmaceutical Contract Manufacturing Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Pharmaceutical Contract Manufacturing Import and Export from 2014-2020
Table Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Pharmaceutical Contract Manufacturing Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Pharmaceutical Contract Manufacturing Participants Value ($) and Market Share (%) in 2019
Table Famar S.A. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Famar S.A. Sales and Growth Rate from 2014-2020
Figure Famar S.A. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Pfizer Centresource Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Pfizer Centresource Sales and Growth Rate from 2014-2020
Figure Pfizer Centresource Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Lonza Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Lonza Sales and Growth Rate from 2014-2020
Figure Lonza Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Recipharm AB Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Recipharm AB Sales and Growth Rate from 2014-2020
Figure Recipharm AB Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Patheon Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Patheon Inc. Sales and Growth Rate from 2014-2020
Figure Patheon Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Aenova Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Aenova Sales and Growth Rate from 2014-2020
Figure Aenova Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Jubilant Life Sciences Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Jubilant Life Sciences Ltd. Sales and Growth Rate from 2014-2020
Figure Jubilant Life Sciences Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Catalent Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Catalent Inc. Sales and Growth Rate from 2014-2020
Figure Catalent Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Boehringer Ingelheim International GmbH. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Boehringer Ingelheim International GmbH. Sales and Growth Rate from 2014-2020
Figure Boehringer Ingelheim International GmbH. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Baxter BioPharma Solutions Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Baxter BioPharma Solutions Sales and Growth Rate from 2014-2020
Figure Baxter BioPharma Solutions Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Pharmaceutical Contract Manufacturing Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global Pharmaceutical Contract Manufacturing Production and Growth Rate Forecast by Regions (2021-2026)
Table Global Pharmaceutical Contract Manufacturing Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global Pharmaceutical Contract Manufacturing Production and Growth Rate Forecast by Types (2021-2026)
Table Global Pharmaceutical Contract Manufacturing Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...